IBUPROFEN MINI- ibuprofen mini 200 mg capsule, liquid filled 
TARGET CORPORATION

----------

Target 11673 683 Ibuprofen 200 mg Mini liquid filled capsules

DRUG FACTS

Active ingredient (in each capsule)

Solubilized ibuprofen equal to 200 mg ibuprofen (NSAID)*

(present as the free acid and potassium salt)

*nonsteroidal anti-inflammatory drug

Purpose

Pain reliever/Fever reducer

Uses

temporarily relieves minor aches and pains due to:

temporarily reduces fever

Warnings

Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke.

These can be fatal. The risk is higher if you use more than directed or for longer than directed.

Do not use

Ask a doctor before use if

Ask a doctor or pharmacist before use if you are

When using this product

Stop use and ask a doctor if

you experience any of the following signs of stomach bleeding:

you have symptoms of heart problems or stroke:

pain gets worse or lasts more than 10 days

fever gets worse or lasts more than 3 days

redness or swelling is present in the painful area

any new symptoms appear

If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away

Directions

if pain or fever does not respond to 1 capsule, 2 capsules may be used

do not exceed 6 capsules in 24 hours, unless directed by a doctor

Other information

Inactive ingredients ammonium hydroxide, FD&C green no. 3, gelatin, iron oxide black, medium chain triglycerides, polyethylene glycol, potassium hydroxide, propylene glycol, purified water, shellac, sorbitan monooleate, sorbital sorbitan

Questions or comments? call 1-800-910-6874

700T-TG-80s-label700T-TG-300s-label700T-TG-160s-label700T-TG-160s-ifc700T-TG-80s-ifc

IBUPROFEN MINI 
ibuprofen mini 200 mg capsule, liquid filled
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-683
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
IBUPROFEN (UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM) IBUPROFEN200 mg
Inactive Ingredients
Ingredient NameStrength
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
FD&C GREEN NO. 3 (UNII: 3P3ONR6O1S)  
GELATIN (UNII: 2G86QN327L)  
WATER (UNII: 059QF0KO0R)  
SORBITAN MONOOLEATE (UNII: 06XEA2VD56)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
FERROUS OXIDE (UNII: G7036X8B5H)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
AMMONIA (UNII: 5138Q19F1X)  
SORBITOL (UNII: 506T60A25R)  
SHELLAC (UNII: 46N107B71O)  
Product Characteristics
ColorgreenScoreno score
ShapeCAPSULESize6mm
FlavorImprint Code 62
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11673-683-32300 in 1 BOTTLE; Type 0: Not a Combination Product12/17/2021
2NDC:11673-683-801 in 1 CARTON12/17/2021
280 in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:11673-683-661 in 1 CARTON12/17/2021
3160 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07920512/17/2021
Labeler - TARGET CORPORATION (006961700)
Registrant - TIME CAP LABORATORIES, INC. (037052099)
Establishment
NameAddressID/FEIBusiness Operations
MARKSANS PHARMA LIMITED925822975manufacture(11673-683)

Revised: 1/2024
Document Id: 0e082f03-459c-4639-e063-6294a90a6689
Set id: c80426d9-e121-c24d-e053-2a95a90acf2f
Version: 3
Effective Time: 20240103
 
TARGET CORPORATION